Literature DB >> 20469340

Which Anti-inflammatory?

W G Bensen, M A Bridge.   

Abstract

Over the past ten years clinicians have been stampeded by the introduction of newer non-steroidal anti-inflammatory drugs. These drugs share analgesic, antipyretic and, most importantly, clinical anti-inflammatory activity and are therefore useful in treating rheumatic diseases. These medications often have less frequent adverse reactions than aspirin and offer alternatives to patients who are intolerant to the more conventional NSAID. The authors review some of the principles which determine choice of the non-steroidal anti-inflammatory drugs, list some specifics on each of the currently available medications, and recommend drugs of choice in a number of specific rheumatic processes.

Entities:  

Year:  1981        PMID: 20469340      PMCID: PMC2538647     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  21 in total

Review 1.  Hyperuricemia and gout. Classification, complications and management.

Authors:  G R Boss; J E Seegmiller
Journal:  N Engl J Med       Date:  1979-06-28       Impact factor: 91.245

2.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.

Authors:  G G Graham; G D Champion; R O Day; P D Paull
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

3.  Effect of ibuprofen dosage on patient response in rheumatoid arthritis.

Authors:  R G Godfrey; S de la Cruz
Journal:  Arthritis Rheum       Date:  1975 Mar-Apr

4.  Combination therapy with naproxen and aspirin in rheumatoid arthritis.

Authors:  R F Willkens; E J Segre
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

5.  Four new anti-inflammatory drugs: responses and variations.

Authors:  E C Huskisson; D L Woolf; H W Balme; J Scott; S Franklin
Journal:  Br Med J       Date:  1976-05-01

6.  Clinical pharmacokinetics of aspirin.

Authors:  G Levy
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

7.  Salicylate-induced gastrointestinal bleeding: comparison between soluble buffered, enteric-coated, and intravenous administration.

Authors:  H Mielants; G Verbruggen; K Schelstraete; E M Veys
Journal:  J Rheumatol       Date:  1979 Mar-Apr       Impact factor: 4.666

8.  Twice-daily dosing of enteric-coated aspirin in patients with rheumatic diseases.

Authors:  W G Bensen; C A Laskin; T W Paton; H A Little; A G Fam
Journal:  J Rheumatol       Date:  1979 May-Jun       Impact factor: 4.666

9.  Indomethacin in rheumatoid arthritis: clinical effects, pharmacokinetics, and platelet studies in responders and nonresponders.

Authors:  N Baber; L D Halliday; W J van den Heuvel; R W Walker; R Sibeon; J P Keenan; T Littler; M L Orme
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

10.  Identification of the biologically active form of sulindac.

Authors:  D E Duggan; K F Hooke; E A Risley; T Y Shen; C G Arman
Journal:  J Pharmacol Exp Ther       Date:  1977-04       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.